Pilot Program 2024 – 10xHealth

Pilot Program: Modules

The program consisted of nine modules. Each module was led by experts in the respective fields, with the support of SmiLe Venture Hub and Medicon Village Innovation’s own experienced employees and coaches.

Module 1

Kicking off your Scale up journey

Led by Good Accelerator, Anna Philipson and the 10xHealth team

Module 2

Business acumen & executive leadership

Led by Thomas Kalling (Lund University) and Styrelse Akademien

Module 3

People, process & structures

Anna Brattström (Lund University)

Module 4

Commercialisation, market expansion & internationalisation

Led by Eversana

Module 5

Digitalisation and new technologies as tools for business value

Led by Mobile Heights

Module 6

Strategic financing for growth

Led by Kunskapspartner and SmiLe Inject

Module 7

Sustainability strategy as a framework for growth

Led by Albaeco

Module 8

Regulatory strategy as a framework for growth

Led by Key2Complaince and SmiLe Incubator

Module 9

Ready to grow 10x more

Led by Good Accelerator

Snapshots Of The 2024 Pilot Program

Pilot Program: Experts

Good Accelerator

Good Accelerator is a platform that focuses on building successful businesses and organizations by harnessing the power of diverse individuals and spreading good leadership principles. They compare their philosophy to a cooperative school of fish where each individual contributes to maintaining course and adapting to changes without losing momentum.

Anna Philipson

Anna has worked as a CEO, other executive management roles, and in board positions within the telecom and other fast-paced industries, both in Sweden and internationally. Among other responsibilities, she has overseen Telia’s billion-dollar investment in fiber and served as the head of Telia’s sales and service division with over 3000 employees.

Lund University

Lund University, founded in 1666, stands among the world’s top universities with 45,000 students and 8,600 staff spread across Lund, Helsingborg, Malmö, and Ljungbyhed. Offering a diverse array of programs and courses, Lund fosters interdisciplinary collaboration, evident in its strong international partnerships spanning 75 countries.

Thomas Kalling

Thomas Kalling is Professor of Strategic Management at the Lund University School of Economics and Management. He leads and has led research for the past 25 years in partnerships with industry on strategic change following macro changes such as deregulation, technology, digitalization, sustainability, globalization and more. He has more than 20 years experience of executive education within strategic management and organisation.

Anna Brattström

Anna Brattström researches the people side of innovation and entrepreneurship. She has engaged with multinational corporations as well as technology-intensive startups, seeking to understand how to organize for innovation, spur teams forward, and initiate and govern complex R&D collaborations between firms. Anna has taught in executive programs at Lund University, Stockholm School of Economics, and INSEAD, and she has been a visiting scholar at Stanford University.

Eversana

Eversana is the leading provider of global commercial services to the life sciences industry. They serve more than 670 organizations, including innovative start-ups and established pharmaceutical companies to advance life science solutions for a healthier world.

Mike Ryan

With more than 25 years of experience in the life science industry, Mike has held global leadership positions in both clinical development and life-sciences software companies. Given this experience, he is highly experienced in the use of technology and understands its impact in simplifying the process of developing and delivering novel therapies and making them more accessible to patients around the world. He has worked with many biotech and pharmaceutical companies to develop clinical pathways that deliver upon the ultimate commercial goals required to ensure success for all stakeholders.

Mobile Heights

Mobile Heights, a non-profit ICT cluster organization, fosters innovation and growth in the digital sphere by facilitating connections among businesses, academia, and society. Its focus areas include Digital Health, Digital Society, and Digital Manufacturing & Materials.

Alma Sandberg

Deputy CEO of Mobile Heights

Janos Olajos

Janos Olajos is Senior Project Manager at Mobile Heights. He has 18+ years of proven R&D project, line-management and change management experience within Ericsson and ST Ericsson and IKEA. In addition to his strong background of managing international/multi-site, and cross-cultural R&D, he has served as deployment manager for large-scale Agile transformation including over 70 cross-functional teams and process adaptations. He also has more than 50 publications in international scientific journals and books.

Kunskapspartner

Kunskapspartner, with over 25 years of experience in strategic business development, assists small to medium-sized companies and organizations in gaining clarity in their operations and achieving greater internal alignment.

Givi Kokaia

As the Managing Partner at Kunskapspartner, Givi Kokaia oversees a team of young and skilled professionals dedicated to assisting small and medium-sized enterprises in enhancing their strategic, digital, and procedural frameworks. With over 10 years of experience in business development, Givi specializes in refining business strategies, optimizing processes, and driving digital marketing and sales initiatives. Their consultancy and advisory experience span various industries and markets, ranging from dynamic startup ecosystems to established corporate environments.

Carl-Henric Nilsson

Carl-Henric Nilsson has over 20 years of experience in strategy development and leadership, specializing in pedagogical development for universities and businesses. He helps executive teams enhance performance levels with a holistic approach, likening his work to the dynamics of racket sports. His key competencies include change management, strategy development, process orientation, and pedagogics.

Albaeco

Albaeco is a non-profit organisation with expertise in sustainable development and research communication on social-ecological systems, resilience, and transformations in the Anthropocene. Albaeco was part in founding the Stockholm Resilience Centre at Stockholm University in 2007, and has operated for more than 25 years in making research insights applicable to different societal actors, including businesses, government agencies, and educators.

Louise Hård af Segerstad

Louise is co-founder and co-director of Albaeco, and a resilience expert and science communicator. Among other things, she has worked with resilience analysis of municipal food supply and educated many different businesses about what sustainability is in a changing, complex world. Also working for Stockholm Resilience Centre (SRC) as a communications strategist.

Fredrik Moberg

Fredrik is co-founder and co-director of Albaeco. He holds a PhD in coral reef ecology/natural resources management from Stockholm University. He works as director at Albaeco and also as a researcher and senior communications advisor at the Stockholm Resilience Centre. Moberg is a specialist in biodiversity, ecosystem services, and resilience of social-ecological systems, with extensive experience advising companies on sustainable innovation and business strategies.

Key2compliance

At Key2Compliance, we make complex things easier for Medical Device, IVD, and Pharma companies. With over 80 dedicated professionals in Scandinavia and Germany, we offer expert consulting and specialized training.

As your trusted partner, we always prioritize your success, ensuring a smooth journey guided by expertise and customer-centric values. We are a full service provider for your regulatory journey with competence areas like QA in IVD, Device and Pharma, Regulatory, Biological Safety, Clinical Development and Training & Courses. We focus on the needs of a small and growing Companies.

Jan Hellqvist

Jan is the CEO of Key2Compliance and he has a background in Pharmaceuticals, In Vitro Diagnostics and Medical Device in companies like AstraZeneca, Orifarm, Stryker, Agilent, TFS and Klifo.

Jan has more than thirty years’ experience in Life Science primarily in Leadership roles and lives with his family in Lund.

SmiLe

SmiLe Venture Hub is a non-profit hub for life science startups, aiming to foster a community of passionate innovators advancing healthcare. They provide comprehensive support, including coaching, fully equipped labs, and a global network of industry partners and investors. Notably, they operate on a no-equity basis, allowing for a neutral platform to launch health innovations.

Kristian Enkvist

Kristian has extensive hands-on experience in innovation, product development and commercialization. He has worked as VP R&D in several global life science companies, buy has also served as CEO and board member in a number of startups. Before taking the role of senior business advisor he has worked as project portfolio lead and business coach at SmiLe.

SmiLe Inject

Smile Inject Capital (Inject) is a Swedish angel investment company specializing in early-stage life science startups. Over three years, they aim to invest SEK 40 million in 10 to 15 promising ventures. They seek innovative health-related solutions in sectors such as medtech, healthtech, biotech, pharma, diagnostics, ehealth, and food tech.

Thomas Unt

Thomas has multi-silo competencies for finance, life Science, retail, entrepreneurship and innovation. He has more than 10 years from the financial industry combined with extensive experience from entrepreneurial development projects with responsibility for venture capital acquisition, IPO and corporate structure. Prior to joining SmiLe, he was CEO and COO for several startups within Finance and Life science.

Pilot Program: Participated Companies

Here are descriptions of the companies that took part in the 10xHealth pilot program.

Hanna Sjöström

CEO, Neola Medical

Neola Medical AB (publ) develops medical devices for continuous monitoring of the lungs of preterm born babies. Immediate detection of complications allows for early treatment and improved care. The patented technology is based on a spectroscopic method developed at Lund University in Sweden.

The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA).

The company’s Certified Adviser is FNCA Sweden AB.

Linda Persson

CEO, NanoEcho

NanoEcho is a venture capital-funded medical technology company that originated from a research group at Lund University. The company is developing a product intended for diagnostics of rectal cancer by mapping the spread of cancer cells to nearby lymph nodes.

Currently, there is a lack of an effective method to detect the spread of cancer to nearby lymph nodes—a crucial piece of information for determining how far the cancer has advanced and determining the appropriate treatment for the patient.

Johan Wäborg

CEO, Iconovo

Iconovo is a Swedish leading CDMO company, offering innovative and effective inhalation platforms to the international pharmaceutical industry. We have several types of patented inhalers that can create significant commercial opportunities for the development of both new pharmaceuticals and generic medicine.

We are a well-established company with patent families and an extensive product pipeline. Our strategy is focused on three core areas: CDMO business, License agreements, and inhaler/product sales.

Cecilia Belfrage

CEO, Uman Sense

Uman Sense, a MedTech innovation company spun off from Lund University, is dedicated to enhancing people’s lives through modern mobile solutions to medical challenges. Their focus lies in creating innovative solutions at the convergence of medicine, mathematics, and mobile technology, with the ultimate goal of revolutionizing healthcare delivery for the benefit of patients.

Through groundbreaking research and development, Uman Sense has devised a mobile stroke alarm system that utilizes wearable technology and advanced algorithms to detect stroke symptoms early, potentially saving countless lives by enabling timely intervention and treatment.

Erik Frick

CEO, Paindrainer

Paindrainer AB is a company developing digital platforms and applications contributing to health and well-being. Paindrainer® is the first evidence-based AI powered digital tool demonstrating improved quality of life in individuals living with chronic pain. The solution is powered by leveraging advanced algorithms and is fully adaptive to each user, a feature called 360o patient-centricity©.

Paindrainer® PD1 is an FDA registered Medical Device Class 1 (510k exemption), MDR compliant and CE certified. The company was founded in 2018 by Prof. Carl Borrebaeck, Dr. Maria Rosén Klement, and Göran Barkfors.

Carl-Magnus Högerkorp

CEO, Cyxone

Cyxone AB is a clinical stage biotech company specializing in the development of transformative therapies against autoimmune and autoinflammatory diseases. Our pipeline includes rabeximod, currently in Phase 2 clinical development for the treatment of rheumatoid arthritis and T20K, currently in early clinical development for the treatment of multiple sclerosis.